Sensorimotor Replacement With Electronic and De-nicotinised Cigarettes
NCT ID: NCT01414998
Last Updated: 2013-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2012-05-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study 1 will seek to confirm the importance of sensorimotor cues by comparing the efficacy of a nicotine-free EC in alleviating withdrawal symptoms, to a behavioural distraction tool (e.g. stress ball) which provides no smoking-related cues.
Study 2 will investigate whether sensorimotor replacements which are more proximal to smoking (i.e. Denics), will be more effective in alleviating withdrawal symptoms than a replacement which only delivers some of the conditioned sensorimotor cues (i.e. ECs).
The investigators hypothesise that the EC will be more effective at reducing withdrawal symptoms compared to the stress ball in Study 1. In Study 2, it is hypothesised that the Denic will be more effective than the EC.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of the Electronic Cigarette on Withdrawal Symptoms
NCT01454362
Combination Nicotine Patch / Lorcaserin for Smoking Cessation
NCT02906644
Pilot Study of a New Nicotine Replacement Therapy
NCT00764439
Electronic Cigarettes in Daily Dependent Smokers
NCT02108626
Evaluation of the Electronic Cigarette Withdrawal Syndrome
NCT06066996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stress Ball
This is the active comparator for study 1
Stress Ball vs Nicotine-free E-Cigarette
In a cross over design, participants will be randomly allocated to:
1. use a stress ball for 5 minutes during a 1 hour controlled experiment. They will also use the stress ball for one day outside of the study centre.
2. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre.
One week later participants will complete the other arm.
De-nicotinised Cigarette
This will be the experimental arm for study 2
Nicotine-free E-Cigarette vs De-nicotinised Cigarette
In a cross over design, participants will be randomly allocated to:
1. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre.
2. smoke 1 de-nicotinised cigarette during a 1 hour controlled experiment. They will also be given a pack to smoke ad-libitum for one day outside of the study centre.
One week later participants will complete the other arm.
Nicotine-free Electronic Cigarette (1)
This will be the experimental arm for study 1
Stress Ball vs Nicotine-free E-Cigarette
In a cross over design, participants will be randomly allocated to:
1. use a stress ball for 5 minutes during a 1 hour controlled experiment. They will also use the stress ball for one day outside of the study centre.
2. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre.
One week later participants will complete the other arm.
Nicotine-free Electronic Cigarette (2)
This will be the active comparator for study 2
Nicotine-free E-Cigarette vs De-nicotinised Cigarette
In a cross over design, participants will be randomly allocated to:
1. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre.
2. smoke 1 de-nicotinised cigarette during a 1 hour controlled experiment. They will also be given a pack to smoke ad-libitum for one day outside of the study centre.
One week later participants will complete the other arm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stress Ball vs Nicotine-free E-Cigarette
In a cross over design, participants will be randomly allocated to:
1. use a stress ball for 5 minutes during a 1 hour controlled experiment. They will also use the stress ball for one day outside of the study centre.
2. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre.
One week later participants will complete the other arm.
Nicotine-free E-Cigarette vs De-nicotinised Cigarette
In a cross over design, participants will be randomly allocated to:
1. use a nicotine-free EC for 5 minutes during a 1 hour controlled experiment. They will also use the EC ad-libitum for one day outside of the study centre.
2. smoke 1 de-nicotinised cigarette during a 1 hour controlled experiment. They will also be given a pack to smoke ad-libitum for one day outside of the study centre.
One week later participants will complete the other arm.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smokes at least 10 cigarettes per day
* Smokes first cigarette within 1 hour of waking
Exclusion Criteria
* acute psychiatric illness
* currently enrolled in other research projects
* current use of ECs or Denics
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen Mary University of London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dunja Przulj
Prinicipal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dunja Przulj
Role: PRINCIPAL_INVESTIGATOR
Queen Mary University of London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tobacco Dependence Research Unit
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
qmul1606
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.